About
Revenio Group Oyj is a Finnish health technology company that specializes in ophthalmic diagnostic devices and software solutions. It is recognized as a global leader in ophthalmological devices, focusing on the early detection and diagnosis of eye diseases such as glaucoma, diabetic retinopathy, macular degeneration, and cataracts. The company offers a range of products, including tonometers for intraocular pressure measurement, fundus imaging devices, perimeters, and clinical software, primarily under the iCare brand. These tools are designed to be fast, user-friendly, and reliable, aiding healthcare professionals in clinical diagnostics and patient care. Revenio's software platform, Oculo, enhances clinical communication, telehealth, remote patient monitoring, and data analytics, improving efficiency and quality in eye care. The company operates globally, with subsidiaries in Europe, the USA, Asia, and Australia. Revenio's solutions are utilized by healthcare professionals, including ophthalmologists, opticians, and optometrists, for screening and monitoring significant eye diseases. The company is publicly listed on Nasdaq Helsinki under the trading code REG1V and is committed to innovation in healthcare technology to support better patient outcomes worldwide.
Technologies
Keywords
Company Information
- Employees250
- Founded2001
- Annual Revenue$117897000
Location
22 Ayritie, Vantaa, Fin, Finland, 01510
